Related Experiment Video
Updated: Mar 11, 2026

Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
Progressive insulin-derived amyloidosis in a patient with type 2 diabetes
Masato Shiba1, Takeshi Kitazawa1
1Department of Plastic and Reconstructive Surgery, Matsunami General Hospital , Gifu , Japan.
Abstract:
Here, we report a case of insulin-derived amyloidosis in the lower abdomen. The mass continued to develop even after the patient ceased injecting insulin into the mass. Histological examination led to a diagnosis of insulin-derived amyloidosis. Excision is preferable in cases of insulin-derived amyloidosis if patient's condition permits.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

